title: Acid-Labile Polyvinylamine Micro- and Nanogel Capsules.
abstract: Hollow nanoparticles represent an emerging area of development for the encapsulation of active ingredients. Expanding the capabilities of these nanomaterials will require continued efforts to infill properties such as size control, biodegradability, and environmental responsiveness. Acid-labile poly(N-vinylformamide) (PNVF) nanocapsules were synthesized by free radical polymerization of N-vinylformamide on the surface of silica nanoparticles. Polymerization in the presence of a novel crosslinker that contains an acid-labile ketal facilitated stable etching of silica nanoparticle templates using sodium hydroxide and recovery of degradable PNVF nanocapsules. The formamido side group of PNVF was then hydrolyzed by extended exposure to sodium hydroxide to produce polyvinylamine (PVAm) micro- and nanocapsules. Both capsule types demonstrated an increasing dissolution rate as pH decreased. In addition, PVAm nanocapsules exhibited swelling in proportion to the relative charge density of the PVAm network (a function of the degree of formamide hydrolysis and pH), presumably due to the repulsion of positively charged amino groups within the elastic shell network. The synthetic approaches reported provide methods to endow nanocapsules with key attributes such as size control, pH sensitive degradation, swelling in response to pH, and amine functionality.
authors.affiliation: Department of Chemical and Petroleum Engineering, The University of Kansas, Lawrence, KS 66047.
authors.forename: Lianjun
authors.initials: L
authors.lastname: Shi
authors.forename: Cory
authors.initials: C
authors.lastname: Berkland
references.citation: J Am Chem Soc. 2001 Jun 13;123(23):5431-6
references.pmid: 11389623
references.citation: Mol Cell Proteomics. 2004 Aug;3(8):746-69
references.pmid: 15143156
references.citation: J Am Chem Soc. 2006 May 10;128(18):5988-9
references.pmid: 16669639
references.citation: Science. 1999 May 14;284(5417):1143-6
references.pmid: 10325219
references.citation: Clin Biochem. 2000 Jul;33(5):345-50
references.pmid: 11018685
references.citation: Angew Chem Int Ed Engl. 1998 Sep 4;37(16):2201-2205
references.pmid: 29711461
references.citation: Mol Pharm. 2005 Jan-Feb;2(1):83-91
references.pmid: 15804181
references.citation: Proc Natl Acad Sci U S A. 2003 Apr 29;100(9):4995-5000
references.pmid: 12704236
references.citation: J Colloid Interface Sci. 2003 Oct 15;266(2):282-94
references.pmid: 14527451
references.citation: Biotechnol Bioeng. 2001 Apr 20;73(2):135-45
references.pmid: 11255161
references.citation: Bioconjug Chem. 1999 Nov-Dec;10(6):993-1004
references.pmid: 10563768
references.citation: Pharm Res. 2006 Sep;23(9):2190-9
references.pmid: 16952009
references.citation: Biomacromolecules. 2005 Nov-Dec;6(6):3433-9
references.pmid: 16283776
references.citation: J Control Release. 1998 Mar 2;52(1-2):119-29
references.pmid: 9685942
references.citation: J Am Chem Soc. 2005 Oct 5;127(39):13448-9
references.pmid: 16190679
references.citation: Biomacromolecules. 2005 Nov-Dec;6(6):3005-9
references.pmid: 16283720
references.citation: Pathophysiol Haemost Thromb. 2006;35(1-2):37-45
references.pmid: 16855345
references.citation: Chemistry. 2006 Jul 24;12(22):5770-8
references.pmid: 16710868
references.citation: J Colloid Interface Sci. 1998 Jan 15;197(2):293-308
references.pmid: 9466871
references.citation: J Am Chem Soc. 2004 Jun 30;126(25):7940-5
references.pmid: 15212543
references.citation: Bioconjug Chem. 2003 Sep-Oct;14(5):934-40
references.pmid: 13129396
references.citation: J Control Release. 2003 Jul 31;90(3):323-34
references.pmid: 12880699
references.citation: Mol Pharm. 2006 May-Jun;3(3):340-50
references.pmid: 16749866